This page contains a Flash digital edition of a book.
See Novozymes Biopharma at CPhI world wide, Frankfurt, Germany, 22-24 Oct 2013 – stand 62E47, hall 6.2


The heat of chili peppers is measured on the Scoville scale.


Hyaluronic acid is now measured on the Hyasis®


scale


Hyasis is the next generation of high-quality hyaluronic acid (HA), setting the new scale for safety, consistency and performance.


Derived from a state-of-the-art Bacillus-based production process utilizing only water for purification, Hyasis is produced with no animal-derived raw materials and no organic solvents for increased safety. This innovative ingredient also offers performance benefits leading to higher productivity and fewer failed batches, enabling greater capacity utilization and therefore reducing costs in manufacturing.


When combined with our proprietary, versatile and safe HA crosslinking technology, Hyasis Link, we can enable the preparation of well characterized and tailored HA hydrogels for an improved injectability profile and better patient outcomes.


Our dedicated research teams offer unique knowledge on characterization, formulation and modification of HA in multiple application areas. By partnering with us, you gain access to ongoing support to develop better products, which are delivered faster to market with the aim of improving quality of life.


Hyasis – the next generation hyaluronic acid Hyasis.com


Product specifications: Hyasis is available in two preparations – 850T (topical) and 850P (parenteral). Hyasis is intended for use in aesthetic medicine, controlled release and formulation of drugs, eye care, joint care and many other applications. ® Hyasis is a registered trademark of Novozymes Biopharma DK A/S. Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers’ business and the use of our planet’s resources.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100